LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

Recruiting

Phase 2

Phase 3

LCH-IVLCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

Sponsor:

North American Consortium for Histiocytosis

Code:

NCT02205762

Conditions

Langerhans Cell Histiocytosis

Eligibility Criteria

Sex: All

Age: 0 - 18

Healthy Volunteers: Not accepted

Interventions

Prednisone

Vinblastine

mercaptopurine

INDOMETHACIN

Methotrexate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-12. This information was provided to ClinicalTrials.gov by North American Consortium for Histiocytosis on 2025-05-25.